Supplementary Figure 3 from Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis
Nikita Sandeep Wagle(American Cancer Society), Amit G. Singal(Southwestern Medical Center), Sulki Park(Texas A&M Health Science Center), David Washburn(Texas A&M Health Science Center), Hye‐Chung Kum(Texas A&M Health Science Center), Robert L. Ohsfeldt(Texas A&M University)
Cited by 0
Related Papers
Cancer statistics, 2023
|CA A Cancer Journal for Clinicians|2023|16.6k
Colorectal cancer statistics, 2023
|CA A Cancer Journal for Clinicians|2023|3.8k
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
|The American Journal of Gastroenterology|2013|227
Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance
|The American Journal of Medicine|2014|177